Joyzyme Group Ltd
Company Profile
Business description
Joyzyme Group Ltd is an investment holding company. The Company and its subsidiaries are principally engaged in research and development, manufacture, marketing, and sale of biological reagents and auxiliary reproductive supplies and equipment, and healthcare products and supplements in the People's Republic of China (the PRC). It operates in two segments: Biological reagents and auxiliary reproductive supplies and equipment, and Healthcare products and supplements. It generates the majority of its revenue from the biological reagents and auxiliary reproductive supplies and equipment segment. Geographically, it generates revenue from the PRC.
Contact
No.16 Yinkui Road
1-3 floor and 5th floor, Building D, Shenzhen Junxuan
Kui Xin Community, Kui Chong Office
Dapeng New District
Shenzhen
CHNT: +86 75533853878
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
101
Stocks News & Analysis
stocks
SpaceX: What investors need to know about its enormous upcoming IPO
stocks
Fair value lifts for toll road operator as Aussie fuel supply steadies
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,906.70 | 42.20 | -0.47% |
| CAC 40 | 8,146.59 | 36.75 | -0.45% |
| DAX 40 | 25,003.04 | 101.66 | -0.40% |
| Dow JONES (US) | 51,078.88 | 46.42 | 0.09% |
| FTSE 100 | 10,338.95 | 70.33 | -0.68% |
| HKSE | 25,395.07 | 3.11 | -0.01% |
| NASDAQ | 27,086.81 | 114.19 | 0.42% |
| Nikkei 225 | 66,419.88 | 514.45 | -0.77% |
| NZX 50 Index | 13,164.47 | 80.08 | -0.60% |
| S&P 500 | 7,599.96 | 19.90 | 0.26% |
| S&P/ASX 200 | 8,665.70 | 41.00 | -0.47% |
| SSE Composite Index | 4,057.30 | 0.44 | -0.01% |